BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12660320)

  • 1. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells.
    Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M
    J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
    Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
    J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.
    Shibuya K; Kanasaki K; Isono M; Sato H; Omata M; Sugimoto T; Araki S; Isshiki K; Kashiwagi A; Haneda M; Koya D
    Diabetes; 2005 Mar; 54(3):838-45. PubMed ID: 15734863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
    Peng H; Carretero OA; Peterson EL; Rhaleb NE
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice.
    Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW
    Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
    Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
    Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A
    Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators.
    Kanasaki K; Haneda M; Sugimoto T; Shibuya K; Isono M; Isshiki K; Araki S; Uzu T; Kashiwagi A; Koya D
    Biochem Biophys Res Commun; 2006 Apr; 342(3):758-65. PubMed ID: 16497271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
    Song CY; Kim BC; Hong HK; Lee HS
    Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension.
    Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the antifibrotic potential of N-acetyl seryl-aspartyl-lysyl-proline sequence peptides.
    Ramasamy V; Ntsekhe M; Sturrock E
    Clin Exp Pharmacol Physiol; 2021 Nov; 48(11):1558-1565. PubMed ID: 34347311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat.
    Deng H; Xu H; Zhang X; Sun Y; Wang R; Brann D; Yang F
    Toxicol Appl Pharmacol; 2016 Mar; 294():1-10. PubMed ID: 26785300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
    Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M
    IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
    Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.
    Rhaleb NE; Peng H; Harding P; Tayeh M; LaPointe MC; Carretero OA
    Hypertension; 2001 Mar; 37(3):827-32. PubMed ID: 11244003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis.
    Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X
    Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats.
    Castoldi G; di Gioia CR; Bombardi C; Preziuso C; Leopizzi M; Maestroni S; Corradi B; Zerbini G; Stella A
    Am J Nephrol; 2013; 37(1):65-73. PubMed ID: 23327833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats.
    Wang M; Liu R; Jia X; Mu S; Xie R
    Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
    Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
    IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.